TSXV:BTI.H - Post by User
Comment by
Sir_Holleron Aug 02, 2015 10:39pm
85 Views
Post# 23984179
RE:RE:RE:RE:RE:Tuesdays price action
RE:RE:RE:RE:RE:Tuesdays price action"the Herceptin news got us red that day, why would anyone be expecting a pop from lsd?"
The ability to predict human outcomes with a mouse model when it comes to brain cancer isn't as strong as the ability to predict human outcomes with a mouse model and Hunter's Syndrome. Rob said that Lysosomal Storage Disease was the perfect model to test Transcend in that it involves just a single mutation and if you can deliver the enzyme where it needs to go you have soved the problem - there is a perfect read-out. Brain cancer is more complex and may only extend life by months. There is also a better validation concerning how mouse testing translates to human testing with Lysosomal Storage Disease I believe.
BTI may have much more information than we were given in the last news release concerning various doseing regimes, and how much of the problem remained in the Scarpa study. Those close to BTI may have an advantage.